Zhongxin Finance, March 23. On the 23rd, the reporter learned from the State Food and Drug Administration that in 2021, drug regulatory authorities at all levels will adhere to the bottom-line thinking, further strengthen the supervision of high-risk key products, and comprehensively strengthen the quality supervision of medical equipment for epidemic prevention and control.
Strengthen the supervision of the production and operation of new coronavirus vaccines, improve the quality and efficiency of batch issuance, and issue more than 5 billion doses of new coronavirus vaccines throughout the year.
In 2021, the investigation and handling of drug cases in my country will continue to increase. Drug regulatory authorities at all levels have completed random inspections of 210,000 batches of drugs, with a pass rate of 99%; completed sampling inspections of nearly 30,000 batches of medical devices, with a pass rate of 95%; The state randomly inspected more than 20,000 batches, and the pass rate was 98%; the products and enterprises that failed the sampling inspection were investigated and punished according to law.
In addition, in 2021, my country's first cosmetics lifetime ban will be issued.
(over)